Tag: Biosimilars

December 6, 2025

Biocon Biologics: Fully Owned Subsidiary – $5.5 Billion Deal

November 21, 2025

Mark Cuban’s Healthcare Disruptions: Plans & Vision

October 30, 2025

STAT+: FDA Biosimilar Pathway, Trump Drug Costs

August 22, 2025

Dulaglutide Biosimilar HbA1c Reduction T2DM Efficacy

June 20, 2025

Essential Information & Key Facts | [Topic of Article]

June 12, 2025

Biosimilars: Policy Maker Collaboration for Access